The efficacy and safety of NeuroWell antidepressant dietary supplement,Deanxit,and their combination in the treatment of mild-to-moderate depression:A randomized clinical trial  

作　　者：Honglei Yin Zhuxin Sui Yutong Wang Dechen Liu Qinglu Wang Yanchao Wang Lei Sun Jinfeng Li Zhen Li Yue Liu Shang Guo Wenwen Wang Hongtao Yin Ping Liu Kezhong Zhang Huaibo Zhang Yajun Liu Yanqiu Liu Qiqi Zhou Dianfang Wei Hui Zhang Shanshan Wang Yaochao Ning Shuang Geng Xuejun Wen Youping Deng Hongwei Wang Yunliang Wang 

机构地区：[1]Neurology Department,ZiBo 148 Hospital,China RongTong Medical Healthcare Group Co.,Ltd.,Zibo,Shandong 255300,China [2]Department of Histology and Embryology,Teaching Department of Basic Medicine,QiluMedical University,Zibo,Shandong 255300,China [3]School of Public Health and Laboratory,Qilu Medical University,Zibo,Shandong 255300,China [4]School of Medicine,The Henan University of Chinese Medicine,Zhengzhou,Henan 450046,China [5]College of Sport and Health,Shandong Sport University,Jinan,Shandong 250102,China [6]Institute of Oncology,The Fifth Medical Centre,Chinese PLA General Hospital,Beijing 100071,China [7]School of Nursing,Qilu Medical University,Zibo,Shandong 255300,China [8]Department of Orthopedic Surgery,Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200023,China [9]Office of Infection Prevention and Control,The Fifth Clinical Medical College of Henan University of Chinese Medicine(Zhengzhou People's Hospital),Zhengzhou,Henan 450002,China [10]Department of Neurology,Zibo Central Hospital,Zibo,Shandong 255036,China [11]Department of Neurology,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China [12]Research Assistant Professor Center for Alcohol Research in Epigenetics,Department of Psychiatry,University of Illinois at Chicago,Chicago,IL 60612,USA [13]Department of Pharmacology,School of Pharmacy,Qilu Medical University,Zibo,Shandong 255300,China [14]Department of Rehabilitation Medicine,Zibo First Hospital,Zibo,Shandong 255200,China [15]XREGEN Research Institute,Hangzhou,Zhejiang 310056,China [16]School of Life Sciences,Zhengzhou University,Zhengzhou,Henan 450001,China [17]Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education,Orthopedic Department of Tongji Hospital,School of Life Science and Technology,Tongji University,Shanghai 200065,China [18]International Institute for Biomedical Biomaterials(I2BM),Zhengzhou,Henan 450018,China [19]Department of Chemical and Life

出　　处：《Genes & Diseases》2024年第6期36-39,共4页基因与疾病（英文）

基　　金：supported by the Second Affiliated Hospital of Zhengzhou University and Zibo 148 Hospital,Qilu Medical University (Shandong,China),XREGEN Research Institute,Shangqiu Medical College (Henan,China).

摘　　要：Depression is the leading global cause of,disability,affecting about 300 milion people worldwide.1;2 Depending on the number and severity of symptoms,depressive episodes can be classified as mild,moderate,and severe.Previous studies have typically focused on the treatment of severe refractory depression,while there have been few studies on the treatment of mild-to-moderate depression.

关 键 词：TREATMENT clinical typically 

分 类 号：R749.4[医药卫生—神经病学与精神病学]